首页 | 本学科首页   官方微博 | 高级检索  
     

单核细胞趋化蛋白-1在慢性阻塞性肺疾病患者发病中的作用探讨
引用本文:王慧,吴希,熊曙光,罗立,王晓红,周会敏,聂晓红. 单核细胞趋化蛋白-1在慢性阻塞性肺疾病患者发病中的作用探讨[J]. 西部医学, 2010, 22(6): 1041-1042,1045
作者姓名:王慧  吴希  熊曙光  罗立  王晓红  周会敏  聂晓红
作者单位:核工业部四一六医院呼吸科,四川,成都,610051
基金项目:四川省卫生厅科研课题 
摘    要:
目的探讨单核细胞趋化蛋白-1(MCP-1)在慢性阻塞性肺疾病(COPD)发病机制中的作用。方法 COPD住院患者38例,入院后达稳定期时分别抽取静脉血用酶联免疫吸附试验法(ELISA)测定诱导痰和血清的MCP-1水平,行BODE评分,选取性别、年龄相配的35例健康人为正常对照,评价两组间的MCP-1水平的差别。结果 COPD组诱导痰及血清MCP-1水平均高于正常对照组。COPD患者诱导痰及血清MCP-1水平与BODE评分呈正相关,与FEV1呈负相关。结论 MCP-1可能参与了COPD气道炎症和重构的发生发展,与患者的预后密切相关。

关 键 词:慢性阻塞性肺疾病  单核细胞趋化蛋白-1  第一秒用力呼气容积  BODE评分

The induced sputum and serum levels and significance of monocyte chemoattractant protein-1 in patients with COPD
Affiliation:WANG Hui,WU Xi,XIONG Shu-guang,et al (Department of Respiratory,The 416 Hospital of Nuclear Industry,Chengdu 610051,China)
Abstract:
Objective To investigate the pathophysiologic roles of monocyte chemoattractant protein-1(MCP-1) in chronic obstructive pulmonary disease(COPD).Methods 38 patients with COPD were enrolled,while 35 gender-and age-matched healthy subjects served as a normal control.Pulmonary function test and BODE score were performed.MCP-1 levels in serum and induced sputum were assayed at the stable stage.Results The induced suptum and serum levels of MCP-1 in the COPD group were both higher than those in the normal control group.The induced sputum and serum levels of MCP-1 in patients with COPD were both negatively correlated with FEV1 and positively correlated with BODE score.Conclusion MCP-1 might contribute to the airway inflammation and renmdeling in COPD,and have close correlation with the prognosis of COPD.
Keywords:Chronic obstructive pulmonary disease  Monocyte chemoattractant protein-1  FEVl  BODE score
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号